660
Participants
Start Date
January 19, 2011
Primary Completion Date
January 27, 2016
Study Completion Date
January 27, 2016
Nabiximols
Taichung
Brussels
Riga
Komárom
Vratsa
Parkville
Miskolc
Szikszó
Nyíregyháza
Rēzekne
Gabrovo
Deszk
Szekszárd
Varna
New York
New York
Torino
Berlin
Distrito Federal
Granada
Philadelphia
Garbagnate Milanese
Benešov
Winston-Salem
Flat Rock
Piacenza
Marietta
Newnan
Stockbridge
Haifa
Chihuahua City
Daytona Beach
Jacksonville
Lynn Haven
Winter Park
Miami
Tampa
Clearwater
Holiday
Stuart
Wetzlar
Ashland
Cleveland
Lünen
Jablonec nad Nisou
Ramat Gan
Saint Louis Park
Missoula
Frankfurt
Ẕerifin
Woodlawn
Kansas City
Wiesbaden
Shreveport
Bossier City
Tainan City
Šiauliai
Houston
Laredo
Beersheba
Salt Lake City
Salt Lake City
Phoenix
Phoenix
Glendale
El Cajon
Klaipėda
Gilroy
Santa Rosa
Lacey
Târgovişte
Craiova
Cluj-Napoca
Oradea
Baia Mare
Baia Mare
Satu Mare
Sibiu
Focşani
Iași
Suceava
Brăila
Constanța
Berlin
České Budějovice
České Budějovice
Most
Nová Ves pod Pleší
Ostrava
Pilsen
Sokolov
Teplice
Jena
Stadtroda
Vilnius
Bialystok
Bielsko-Biala
Bydgoszcz
Czeladź
Częstochowa
Częstochowa
Działdowo
Gdansk
Gliwice
Kłodzko
Opole
Ostrowiec Świętokrzyski
Poznan
Warsaw
Warsaw
Włocławek
Ponce
San Juan
Bucharest
Bucharest
Bury
Bury St Edmunds
Cheltenham
Crumpsall
Edinburgh
Edinburgh
Gorleston-on-Sea
Leeds
Manchester
Withington
Norwich
Plymouth
Weston-super-Mare
Lead Sponsor
Otsuka Pharmaceutical Development & Commercialization, Inc.
INDUSTRY
Jazz Pharmaceuticals
INDUSTRY